STOCK TITAN

Argan (AGX) director exercises 5,000 options, sells 3,636 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ARGAN INC director Jeffrey John Ronald Jr. reported an option exercise and share sale. On April 21, 2026, he exercised a stock option for 5,000 shares of common stock at $37.13 per share using a net settle method, receiving 4,698 shares of common stock.

That same day, he sold 3,636 shares of common stock in open-market transactions at an average price of $615.40 per share. After these transactions, he held 4,698 shares directly and 8,000 shares indirectly through a John R. Jeffrey IRA.

Positive

  • None.

Negative

  • None.
Insider Jeffrey John Ronald Jr.
Role null
Sold 3,636 shs ($2.24M)
Type Security Shares Price Value
Exercise Option to Purchase Common Stock 5,000 $37.13 $186K
Sale Common Stock 3,636 $615.40 $2.24M
Exercise Common Stock 4,698 $37.13 $174K
holding Common Stock -- -- --
Holdings After Transaction: Option to Purchase Common Stock — 6,500 shares (Direct, null); Common Stock — 0 shares (Direct, null); Common Stock — 8,000 shares (Indirect, John R. Jeffrey, IRA)
Footnotes (1)
  1. On April 21, 2026, the Reporting Person sold 3,636 shares of the Issuer's common stock on the open market at an average price of $615.40 per share. On April 21, 2026, the Reporting Person exercised his stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method.
Shares sold 3,636 shares Open-market sale on April 21, 2026
Sale price $615.40 per share Average price for 3,636 shares sold
Options exercised 5,000 shares Stock option exercise on April 21, 2026
Option exercise price $37.13 per share Strike price of option granted December 14, 2021
Shares received on exercise 4,698 shares Common stock delivered via net settle method
Direct holdings after transactions 4,698 shares Common stock held directly after April 21, 2026
Indirect IRA holdings 8,000 shares Common stock held via John R. Jeffrey, IRA
open market financial
"sold 3,636 shares of the Issuer's common stock on the open market"
An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.
net settle method financial
"exercised his stock option ... using the net settle method"
stock option financial
"exercised his stock option awarded on December 14, 2021"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Jeffrey John Ronald Jr.

(Last)(First)(Middle)
C/O ARGAN, INC.
4075 WILSON BOULEVARD, SUITE 440

(Street)
ARLINGTON VIRGINIA 22203

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/21/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/21/2026S3,636(1)D$615.40D
Common Stock04/21/2026M4,698(2)A$37.134,698D
Common Stock8,000IJohn R. Jeffrey, IRA
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to Purchase Common Stock$37.1304/21/2026M5,000(2)12/14/202212/14/2031Common Stock5,000$37.136,500D
Explanation of Responses:
1. On April 21, 2026, the Reporting Person sold 3,636 shares of the Issuer's common stock on the open market at an average price of $615.40 per share.
2. On April 21, 2026, the Reporting Person exercised his stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method.
/s/ John R. Jeffrey, Jr.04/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Argan (AGX) director Jeffrey John Ronald Jr. report?

He reported exercising options for 5,000 Argan shares and selling 3,636 shares. The exercise used a net settle method, delivering 4,698 shares, while the 3,636 shares were sold in open-market trades at an average price of $615.40 per share.

How many Argan (AGX) shares did the director sell and at what price?

He sold 3,636 shares of Argan common stock at an average price of $615.40 per share. These were open-market transactions executed on April 21, 2026, as disclosed in the Form 4 footnotes for the reporting person.

What stock options did the Argan (AGX) director exercise in this Form 4?

He exercised a stock option granted on December 14, 2021 to purchase 5,000 Argan common shares at $37.13 per share. The option exercise used a net settle method, resulting in 4,698 shares of common stock being delivered to him.

What are the director’s Argan (AGX) holdings after these transactions?

After the transactions, he held 4,698 Argan common shares directly and 8,000 shares indirectly. The indirect holdings are in an account identified as “John R. Jeffrey, IRA,” reflecting ownership through an individual retirement account rather than direct personal registration.

What does “net settle method” mean in the Argan (AGX) option exercise?

In this context, the net settle method means the director did not receive all 5,000 shares underlying the option. Instead, 4,698 shares were delivered after using part of the value to cover costs, such as exercise price or related obligations, as described in the footnote.